Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Prostatic Neoplasms 241Lymphoma 178Lymphoma, Large B-Cell, Diffuse 172Precursor Cell Lymphoblastic Leukemia-Lymphoma 88Lymphoma, Follicular 79Lymphoma, Non-Hodgkin 73Burkitt Lymphoma 66Multiple Myeloma 64Leukemia 58Hodgkin Disease 45Lymphoma, Mantle-Cell 41Neoplasms 35Lymphoma, T-Cell, Peripheral 31Lymphoma, B-Cell 30Lymphoma, B-Cell, Marginal Zone 28Lymphoma, Large-Cell, Anaplastic 26Neoplasm Metastasis 25Lymphoma, Large-Cell, Immunoblastic 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Neoplasms, Plasma Cell 21Recurrence 20Immunoblastic Lymphadenopathy 15Dendritic Cell Sarcoma, Interdigitating 15Lymphoma, T-Cell 14Leukemia, Biphenotypic, Acute 10Waldenstrom Macroglobulinemia 9Blast Crisis 9Primary Myelofibrosis 8Myelodysplastic Syndromes 8

Interventions

ruxolitinib 4Specimen Handling 3Biopsy 3venetoclax 2trametinib 1sonidegib 1siltuximab 1regorafenib 1ponatinib 1pomalidomide 1pevonedistat 1pertuzumab 1pembrolizumab 1pelcitoclax 1peginterferon alfa-2b 1palbociclib 1olaparib 1neratinib 1luspatercept 1lorlatinib 1lenvatinib 1itacitinib 1imetelstat 1idelalisib 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1dehydroftorafur 1darolutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytosis × Prednisone × Clear all
NCT00946270 2019-06-10

Pomalidomide for Myelofibrosis Patients

M.D. Anderson Cancer Center

Phase 2 Completed
70 enrolled 10 charts
Myeloid

Polycythemia Vera, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡